Vortioxetine in Patients With Depression Coexisting With General Anxiety Disorder (GAD)
Status:
Completed
Trial end date:
2021-03-09
Target enrollment:
Participant gender:
Summary
This study evaluates the effectiveness of vortioxetine on depressive symptoms in patients
with depression coexisting with generalized anxiety disorder.